← Back to Search
Rutin Inhibits Streptococcus Suis Biofilm Formation By Affecting CPS Biosynthesis
Shuai Wang, C. Wang, Lingfei Gao, H. Cai, Yonghui Zhou, Yan-bei Yang, Chang-geng Xu, Wen-ya Ding, Jianqing Chen, I. Muhammad, X. Chen, Xinmiao He, Di Liu, Yanhua Li
Published 2017 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Streptococcus suis (S. suis) form biofilms and causes severe diseases in humans and pigs. Biofilms are communities of microbes embedded in a matrix of extracellular polymeric substances. Eradicating biofilms with the use of antibiotics or biocides is often ineffective and needs replacement with other potential agents. Compared to conventional agents, promising and potential alternatives are biofilm-inhibiting compounds without impairing growth. Here, we screened a S. suis adhesion inhibitor, rutin, derived from Syringa. Rutin, a kind of flavonoids, shows efficient biofilm inhibition of S. suis without impairing its growth. Capsular polysaccharides(CPS) are reported to be involved in its adherence to influence bacterial biofilm formation. We investigated the effect of rutin on S. suis CPS content and structure. The results showed that rutin was beneficial to improve the CPS content of S. suis without changing its structure. We further provided evidence that rutin specifically affected S. suis biofilm susceptibility by affecting CPS biosynthesis in vitro. The study explores the antibiofilm potential of rutin against S. suis which can be used as an adhesion inhibitor for the prevention of S. suis biofilm-related infections. Nevertheless, rutin could be used as a novel natural inhibitor of biolfilm and its molecular mechanism provide basis for its pharmacological and clinical applications.
This paper references
A Colorimetric Method for the Determination of Sugars
M. Dubois (1951)
The type-specific polysaccharides of Streptococcus suis
S. Elliott (1978)
Adherence of Streptococcus sanguis clinical isolates to smooth surfaces and interactions of the isolates with Streptococcus mutans glucosyltransferase
S. Hamada (1981)
Comparative preparation methods of sialylated capsule antigen from Streptococcus suis type 2 with type specific antigenicity.
M. Katsumi (1996)
The biochemistry and genetics of capsular polysaccharide production in bacteria.
I. Roberts (1996)
Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2.
N. Charland (1996)
Biofilm Susceptibility to Antimicrobials
P. Gilbert (1997)
Identification and Characterization of thecps Locus of Streptococcus suis Serotype 2: the Capsule Protects against Phagocytosis and Is an Important Virulence Factor
Hilde E. Smith (1999)
The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.
E. Middleton (2000)
Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers
I. Erlund (2000)
Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae
J. Morona (2000)
CpsB Is a Modulator of Capsule-associated Tyrosine Kinase Activity in Streptococcus pneumoniae *
M. H. Bender (2001)
Spontaneous sequence duplication within an open reading frame of the pneumococcal type 3 capsule locus causes high‐frequency phase variation
R. D. Waite (2001)
Streptococcus suis Interactions with the Murine Macrophage Cell Line J774: Adhesion and Cytotoxicity
M. Segura (2002)
The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae.
J. Morona (2004)
CpsE from Type 2 Streptococcus pneumoniae Catalyzes the Reversible Addition of Glucose-1-Phosphate to a Polyprenyl Phosphate Acceptor, Initiating Type 2 Capsule Repeat Unit Formation
R. Cartee (2005)
Survival strategies of infectious biofilms.
C. A. Fux (2005)
Invasive Disease and Toxic Shock due to Zoonotic Streptococcus suis: An Emerging Infection in the East?
S. Sriskandan (2006)
Characterization of In Vitro Biofilm-Associated Pneumococcal Phase Variants of a Clinically Relevant Serotype 3 Clone
M. C. McEllistrem (2006)
Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19 F and 23 F strains in Japan
L. Qin (2006)
Biofilm Formation by Streptococcus pneumoniae: Role of Choline, Extracellular DNA, and Capsular Polysaccharide in Microbial Accretion
M. Moscoso (2006)
Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan
L. Qin (2006)
Genetic Analysis of the Capsular Biosynthetic Locus from All 90 Pneumococcal Serotypes
S. Bentley (2006)
[An outbreak of human Streptococcus suis serotype 2 infections presenting with toxic shock syndrome in Sichuan, China].
W. Yang (2006)
Antimicrobial susceptibility and serotype distribution of Streptococcus
L. Qin (2006)
[Analysis of monosaccharides and uronic acids in polysaccharides by pre-column derivatization with p-aminobenzoic acid and high performance liquid chromatography].
G. Hao (2007)
Characterization of Colony Morphology Variants Isolated from Streptococcus pneumoniae Biofilms
M. Allegrucci (2007)
Streptococcus suis infections in humans: the Chinese experience and the situation in North America
M. Gottschalk (2007)
Characterization of colony morphology
M. Allegrucci (2007)
Novel anti-adherence activity of mulberry leaves: inhibition of Streptococcus mutans biofilm by 1-deoxynojirimycin isolated from Morus alba.
B. Islam (2008)
Naturally Occurring Molecules as Alternative Therapeutic Agents against Cariogenic Biofilms
H. Koo (2009)
Structure determination of Streptococcus suis serotype 2 capsular polysaccharide.
M. Van Calsteren (2010)
Streptococcus suis: a new emerging or an old neglected zoonotic pathogen?
M. Gottschalk (2010)
Genetic analysis of the capsular polysaccharide synthesis locus in 15 Streptococcus suis serotypes.
K. Wang (2011)
Reduced virulence is an important characteristic of biofilm infection of Streptococcus suis.
Y. Wang (2011)
New approaches for treating staphylococcal biofilm infections
Megan R. Kiedrowski (2011)
The Relative Roles of Factor H Binding Protein, Neisserial Surface Protein A, and Lipooligosaccharide Sialylation in Regulation of the Alternative Pathway of Complement on Meningococci
L. Lewis (2012)
Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal
D. McDougald (2012)
Genetic Analysis of Capsular Polysaccharide Synthesis Gene Clusters from All Serotypes of Streptococcus suis: Potential Mechanisms for Generation of Capsular Variation
Masatoshi Okura (2013)
Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells
B. Conlon (2014)
Structural Characterization of the Extracellular Polysaccharide from Vibrio cholerae O1 El-Tor
Fitnat H. Yildiz (2014)
The global threat of antimicrobial resistance: science for intervention
I. Roca (2015)
Emodin affects biofilm formation and expression of virulence factors in Streptococcus suis ATCC700794
Yan-bei Yang (2015)
Quercitrin, an Inhibitor of Sortase A, Interferes with the Adhesion of Staphylococcal aureus
Bingrun Liu (2015)
Metabolomics-Based Screening of Biofilm-Inhibitory Compounds against Pseudomonas aeruginosa from Burdock Leaf
Z. Lou (2015)
Effect of the glycosyltransferases on the capsular polysaccharide synthesis of Streptococcus suis serotype 2.
Yanyan Zhang (2016)
Syringa oblata Lindl. Aqueous Extract Is a Potential Biofilm Inhibitor in S. suis
Jingwen Bai (2017)
This paper is referenced by
Effect of Syringopicroside Extracted from Syringa oblata Lindl on the Biofilm Formation of Streptococcus suis
Yang Tang (2021)
Phytomolecules investigated for the prevention and treatment of urinary stones
Fatima Ezzahra El oumari (2021)
Rutin, A Natural Inhibitor of IGPD Protein, Partially Inhibits Biofilm Formation in Staphylococcus xylosus ATCC700404 in vitro and in vivo
Q. Qu (2021)
Insects as a source of phenolic compounds and potential health benefits
M. C. Niño (2021)
Study of dietary polyphenols from natural herbal sources for providing protection against human degenerative disorders
Chaiti Mukherjee (2021)
Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor
Pawan K. Agrawal (2021)
Chitosan Oligosaccharides Coupling Inhibits Bacterial Biofilm-Related Antibiotic Resistance against Florfenicol
Xianghua Yuan (2020)
Antibacterial activity of flavonoids and their structure–activity relationship: An update review
F. Farhadi (2019)
Rutin, a Natural Inhibitor of IGPD Protein, Inhibits the Biofilm Formation in Staphylococcus xylosus ATCC700404
God’spower Bello-Onaghise (2019)
In vitro activity and In vivo efficacy of Isoliquiritigenin against Staphylococcus xylosus ATCC 700404 by IGPD target
Q. Qu (2019)
Combined effect of a natural flavonoid rutin from Citrus sinensis and conventional antibiotic gentamicin on Pseudomonas aeruginosa biofilm formation
Murugesan Sathiya Deepika (2018)
Streptococcus suis biofilm: regulation, drug-resistance mechanisms, and disinfection strategies
Y. Wang (2018)
Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part II - Pathogenesis.
J. Dutkiewicz (2018)
Spectrum-Effect Relationships Between the Bioactive Ingredient of Syringa oblata Lindl. Leaves and Its Role in Inhibiting the Biofilm Formation of Streptococcus suis
Yanyan Liu (2018)
Homology Modeling and Virtual Screening to Discover Potent Inhibitors Targeting the Imidazole Glycerophosphate Dehydratase Protein in Staphylococcus xylosus
Xing-ru Chen (2017)